TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
TENX

Tenax Therapeutics Inc

Healthcare · Biotechnology

1.90$ +2.1% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

Tenax Therapeutics Inc (TENX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 122 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TENX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
12 12 14 11 100 97 112 106 103 104 123 122
12 12 14 11 100 97 112 106 103 104 123 122
11 9.8 13 9.4 98 95 111 105 99 98 119 118
11 9.8 13 9.4 98 95 111 105 99 98 119 118
0.6 3.6 2.0 1.7 2.6 4.7 2.8 2.5 6.6 7.2 8.5 8.1
0.6 3.6 2.0 1.7 2.6 4.7 2.8 2.5 6.6 7.2 8.5 8.1
0.2 0.5 0.4 0.3 – – – – – – – –
0.1 2.1 1.1 0.9 1.6 3.2 1.8 0.6 5.6 6.0 6.3 6.8
11 8.1 12 8.9 97 92 109 103 96 97 115 114
-294 -297 -301 -305 -309 -315 -325 -336 -352 -367 -383 -401
0.3 0.2 1.2 2.0 21 15 37 40 40 39 45 51

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?